Agentix (AGTX) Price & Analysis
AGTX Stock Chart & Stats
- Day’s Range
- $0.05 - $0.05
- 52-Week Range
- $0.01 - $0.07
- Previous Close
- $0.05
- Volume
- 1
- Average Volume (3M)
- 25.35K
- Market Cap
- $2.00M
- Enterprise Value
- $674.74B
- Total Cash (Recent Filing)
- $38
- Total Debt (Recent Filing)
- $379.70K
- Price to Earnings (P/E)
- ―
- Beta
- 0.01
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
AGTX FAQ
What was Agentix’s price range in the past 12 months?
What is Agentix’s market cap?
When is Agentix’s upcoming earnings report date?
Is Agentix overvalued?
Does Agentix pay dividends?
What is Agentix’s EPS estimate?
How many shares outstanding does Agentix have?
Which hedge fund is a major shareholder of Agentix?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Agentix
Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Riazul Huda
- Employees
- 2
- Website
- www.agentixcorp.com
- Address
- 32932 Pacific Coast Highway, Dana Point, CA, 92629, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 6 | 2 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 11 | 1 | 0 |